Dr. Michael Dahm
Chief Medical Officer
Chief Medical Officer
Oryx Translational Medicine
Germany
Biography
Dr. Dahm is a medical doctor and molecular biologist with more than 10 years management experience in pharmaceutical companies. Prior to joining ORYX in 2009, he was Managing Director of HEXAL Biotech Forschungs GmbH and HEXAL Gentech Forschungs GmbH, where he was mainly responsible for the development of generic recombinant erythropoietin (EPO) and for the tumor cell enrichment system OncoQuick®.
Research Interest
Molecular biology
